<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS107871</article-id>
<article-id pub-id-type="doi">10.1101/2020.12.04.412494</article-id>
<article-id pub-id-type="archive">PPR249487</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The aging whole blood transcriptome reveals a potential role of FASLG in COVID-19</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>de Almeida Chuffa</surname>
<given-names>Luiz Gustavo</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>dos Santos Souza</surname>
<given-names>Jeferson</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Mello</surname>
<given-names>Mariana Costa</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Oliveira Neto</surname>
<given-names>Mario</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Carvalho</surname>
<given-names>Robson Francisco</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Structural and Functional Biology, UNESP - São Paulo State University, Institute of Biosciences, Botucatu, 18618-689, São Paulo, Brazil</aff>
<aff id="A2">
<label>2</label>Department of Biophysics and Pharmacology, UNESP - São Paulo State University, Institute of Biosciences, Botucatu, 18618-689, São Paulo, Brazil</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>
<bold>Corresponding author:</bold> Luiz Gustavo de Almeida Chuffa, Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil, Zip Code: 510; P.O Box: 18618-689, Rubião Júnior, s/n, Botucatu, SP - Brazil, Phone: +55 (14) 3880-0027, Fax: +55 (14) 3811-6361. <email>luiz-gustavo.chuffa@unesp.br</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>07</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>06</day>
<month>12</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">The risk for severe illness from COVID-19 increases with age as older patients are at the highest risk. Although it is still unclear whether the virus is blood-transmitted, the viral RNA is detected in serum. Identifying how Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacts with specific blood components during aging is expected to guide proper therapies. Considering that all human coronavirus require host cellular molecules to promote infection, we investigated the aging whole blood transcriptome from the Genotype-Tissue Expression (GTEx) database to explore differentially expressed genes (DEGs) translated into proteins potentially interacting with viral proteins. From a total of 22 DEGs in aged blood, five genes <italic>(FASLG, CTSW,</italic> <italic>CTSE, VCAM1,</italic> and <italic>BAG3)</italic> changed expression during aging. These age-related genes are involved in immune response, inflammation, cell component and cell adhesion, and platelet activation/aggregation. Both males and females older than 50 overexpress <italic>FASLG</italic> compared with younger adults (20-30 years old), possibly inducing a hyper-inflammatory cascade that activates specific immune cells. Furthermore, the expression of cathepsins <italic>(CTSW</italic> and <italic>CTSE)</italic> and the anti-apoptotic co-chaperone molecule <italic>BAG3</italic> was significantly increased throughout aging in both gender. By exploring publicly available Single-Cell RNA-Sequencing (scRNA-Seq) data on peripheral blood of SARS-CoV-2-infected patients, we found <italic>FASLG</italic> and <italic>CTSW</italic> expressed mainly in natural killer (NK) cells and CD8+ (cytotoxic) T lymphocytes whereas <italic>BAG3</italic> was expressed in CD4+ T cells, naive T cells, and CD14+ monocytes. The increased expression of <italic>FASLG</italic> in blood during aging may explain why older patients are more prone to severe acute viral infection complications. These results indicate <italic>FASLG</italic> as a prognostic candidate and potential therapeutic target for more aggressive clinical manifestation of COVID-19.</p>
</abstract>
<kwd-group>
<kwd>COVID-19</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>whole blood</kwd>
<kwd>FASL</kwd>
<kwd>tumor necrosis factor ligand</kwd>
<kwd>elderly patients</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">Coronavirus disease 2019 (COVID-19) is a pandemic infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [<xref ref-type="bibr" rid="R1">1</xref>]. This virus is associated with a broad spectrum of respiratory disturbances, varying from upper airway symptoms to aggressive pneumonia [<xref ref-type="bibr" rid="R2">2</xref>]. In lung parenchyma, it produces alveolar edema, fibrin deposition, and hemorrhage [<xref ref-type="bibr" rid="R2">2</xref>]. Notably, vascular changes are one of the distinctive features of COVID-19. Many patients have demonstrated clinical signs of thrombotic microangiopathy [<xref ref-type="bibr" rid="R3">3</xref>], with intravascular coagulation and thrombosis associated with multisystem organ failure [<xref ref-type="bibr" rid="R4">4</xref>].</p>
<p id="P3">Although SARS-CoV-2 affects the lungs primordially, there is convincing evidence that it alters the coagulation processes in severe cases [<xref ref-type="bibr" rid="R5">5</xref>]. The formation of blood clots disrupts circulation due to thrombosis, pulmonary embolism, and heart attacks [<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref>]. The association of these changes in coagulation and protein aggregates with alterations in inflammatory parameters results in an increase of COVID-19 mortality at alarming proportions. The micro-thrombotic environment arises from hyperactivation of the coagulation cascade associated with hyper-intense inflammation and immune activities [<xref ref-type="bibr" rid="R6">6</xref>]. Of note, the clotting process is complex and likely orchestrated by the massive release of pro-inflammatory mediators, cytokines, and tumor necrosis factor (TNF), mainly released from monocytes and endothelial cells [<xref ref-type="bibr" rid="R6">6</xref>]. The fact that the mortality rate of patients aged 60 years and over is higher than those under 60 years is indisputable [<xref ref-type="bibr" rid="R7">7</xref>]. Most of these critical cases are associated with the “cytokine storm,” as these exacerbated immune reactions may lead to an early death of elderly people regardless of comorbidities related to more severe cases [<xref ref-type="bibr" rid="R8">8</xref>].</p>
<p id="P4">Recent findings are correlating the blood subtype with viral susceptibility and infection [<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref>]. However, the individual molecular machinery of blood cells may be detrimental for the grade and type of response, such as exacerbated or reduced inflammation. Considering that aging is one of the most significant risk factors for severe cases of COVID-19, it is essential to determine blood host genetic variation throughout the aging process. The evolutionary conservation between the 2019 novel SARS-CoV-2 and SARS-CoV [<xref ref-type="bibr" rid="R11">11</xref>] allows the possibility to understand similarities and differences between these coronaviruses into public databases. Using computational predictions of SARS-CoV–human protein-protein interactions (PPIs), we can identify possible mechanisms behind the viral infection and identify potential drug targets [<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref>].</p>
<p id="P5">Considering that older individuals, with or without comorbidities, are more prone to develop more severe cases of COVID-19, including those related to blood perturbations, we investigated the whole blood transcriptome data during aging using the Genotype-Tissue Expression (GTEx) database [<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>]. This strategy provided significant insights into age-associated target genes and how they can predict SARS-CoV-2-interactions in aged blood components.</p>
</sec>
<sec id="S2" sec-type="materials | methods">
<title>Materials and Methods</title>
<sec id="S3">
<title>Whole blood transcriptome during aging</title>
<p id="P6">We used whole blood RNA-Seq data from 670 males and females available at the GTEx portal (release V8) (<ext-link ext-link-type="uri" xlink:href="https://www.gtexportal.org/">https://www.gtexportal.org/</ext-link>) [<xref ref-type="bibr" rid="R16">16</xref>]. The BioJupies platform (<ext-link ext-link-type="uri" xlink:href="https://amp.pharm.mssm.edu/biojupies/">https://amp.pharm.mssm.edu/biojupies/</ext-link>) [<xref ref-type="bibr" rid="R17">17</xref>] was used to find the differentially expressed genes (DEGs) in whole blood samples over aging (20-79 years-old). The samples were selected and matched per age range: 30-39, 40-49, 50-59; 60-69 and 70-79. Then, age ranges were individually compared with young adults (aged 2029). Genes with Log2 fold-change ≥ |1| ≤ |1| and false discovery rate (FDR) &lt; 0.05 were considered as DEGs (<xref ref-type="supplementary-material" rid="SD1">Supplementary Tables 1-5</xref>). The DEGs were used to identify protein-protein interaction networks and perform gene ontology enrichment analyses (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 1</xref>).</p>
</sec>
<sec id="S4">
<title>Virus-host protein-protein interactions (PPIs) overlapping DEGs in whole blood with SARS-CoV-related perturbations</title>
<p id="P7">We first selected SARS-CoV-2 cell entry mediators using the human proteins available in the COVID-19 Cell Atlas (<ext-link ext-link-type="uri" xlink:href="https://www.covid19cellatlas.org/">https://www.covid19cellatlas.org/</ext-link>). In addition to this screening, we compared upregulated and downregulated DEGs in the whole blood during aging with the corresponding proteins that interact with HCoVs (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 9</xref>) by using publicly available databases. To uncover HCoVs-human PPIs, we used data from the Pathogen-Host Interactome Prediction using Structure Similarity (P-HIPSTer, <ext-link ext-link-type="uri" xlink:href="http://phipster.org/">http://phipster.org/</ext-link>) database. P-HIPSTer is a broad protein catalog of the virus-human interactions upon structural information with an experimental validation rate of approximately 76% [<xref ref-type="bibr" rid="R18">18</xref>]. Our research has used P-HIPSTer to identify proteins potentially interacting with SARS-CoV-2 in other tissues [<xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R20">20</xref>].</p>
<p id="P8">The relative expression of <italic>FASLG, CTSW, CTSE, VCAM1, and BAG3</italic> (TMM normalized; V8 cohort) was also performed independently in male and female samples using One-way ANOVA followed by Tukey's test. The results were analyzed with GraphPad Prism v. 6.00 for Windows (GraphPad Software, La Jolla, California, USA). Significant differences were set at P &lt; 0.05.</p>
</sec>
<sec id="S5">
<title>Tissue-specific interaction networks of potential SARS-CoV-host blood interactome</title>
<p id="P9">The HumanBase tool (<ext-link ext-link-type="uri" xlink:href="https://hb.flatironinstitute.org">https://hb.flatironinstitute.org</ext-link>) [<xref ref-type="bibr" rid="R21">21</xref>] was used to provide whole blood-specific networks based on upregulated genes during aging that code for proteins potentially interacting with SARS-CoV according to P-HIPSTer. We considered five functional modules: co-expression, interaction, transcription factor binding, gene set enrichment analysis perturbations and microRNA targets as active interaction sources, applying a minimum interaction confidence of 0.12. The maximum number of genes was set as 15.</p>
</sec>
<sec id="S6">
<title>Gene Ontology Enrichment analysis of differentially expressed genes during aging</title>
<p id="P10">We performed the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and Gene Ontology enrichment analysis (Biological Processes) to identify the functions of DEGs by using the EnrichR database (<ext-link ext-link-type="uri" xlink:href="http://amp.pharm.mssm.edu/Enrichr/">http://amp.pharm.mssm.edu/Enrichr/</ext-link>) [<xref ref-type="bibr" rid="R22">22</xref>]. Top enriched terms were generated according to the lowest p-value &lt; 0.05 (Fisher's exact test). The molecular function and protein class related to the blood components during aging were performed in the PANTHER classification system v. 11.0 (<ext-link ext-link-type="uri" xlink:href="http://www.pantherdb.org/">http://www.pantherdb.org/</ext-link>) [<xref ref-type="bibr" rid="R23">23</xref>]. We used the UniProtKB database (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/">http://www.uniprot.org/</ext-link>) to obtain functional information of the identified proteins.</p>
</sec>
<sec id="S7">
<title>Protein-protein interaction (PPI) networks based on blood gene expression profile during aging</title>
<p id="P11">The genes that appeared overexpressed in aged blood samples were analyzed by STRING online tool (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>) [<xref ref-type="bibr" rid="R24">24</xref>]. The metasearch STRING database (Search Tool for Retrieval of Interacting Genes, v. 10.5) was used for mapping PPI enrichment. We considered the following settings: text mining, databases, experiments, and co-occurrence as sources of interaction. The minimum interaction score was 0.900 (highest confidence); in the networks, the disconnected nodes were hidden to show reliable interactions exclusively. The PPI enrichment P-value indicates the statistical significance registered by STRING. (access in October 2020).</p>
</sec>
<sec id="S8">
<title>Single-cell transcriptomic analysis of human peripheral blood cells</title>
<p id="P12">We investigated the expression of selected genes <italic>(FASLG, CTSW, CTSE, VCAM</italic> and <italic>BAG3)</italic> in distinct blood cell populations based on previously published human single-cell RNA-seq data [<xref ref-type="bibr" rid="R25">25</xref>]. This single-cell dataset is available at the COVID-19 Cell Atlas (<ext-link ext-link-type="uri" xlink:href="https://www.covid19cellatlas.org/">https://www.covid19cellatlas.org/</ext-link>) and was explored using the cellxgene interactive viewer (<ext-link ext-link-type="uri" xlink:href="https://cellxgene.cziscience.com">https://cellxgene.cziscience.com</ext-link>). The dataset includes peripheral blood mononuclear cells (PBMCs) populations from patients hospitalized with COVID-19 (n=7); patients with acute respiratory distress syndrome (n = 4), and healthy controls displaying no diasease (n = 6).</p>
</sec>
<sec id="S9">
<title>Structural analysis of the Fas and FasL</title>
<p id="P13">The genes Fas (genbank code: XP_006717882.1) and FasL (genbank code: NP_000630.1) were obtained on NCBI GenBank, and protein structure blast of these sequences were performed using NCBI blastp suite [<xref ref-type="bibr" rid="R26">26</xref>]. Next, PDB structures and FASTA sequences were downloaded on protein data Bank [<xref ref-type="bibr" rid="R27">27</xref>], and the sequences obtained from GenBank and PDB were aligned on LALIGN [<xref ref-type="bibr" rid="R28">28</xref>]. Finally, sequence molecular mass calculation was evaluated using ProtParam expasy [<xref ref-type="bibr" rid="R29">29</xref>].</p>
</sec>
<sec id="S10">
<title>Data representation and analysis</title>
<p id="P14">The comparison of blood candidate genes was based on Venn diagrams using the Venny2.0 tool (<ext-link ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>) [<xref ref-type="bibr" rid="R30">30</xref>]. Heatmaps and Scatter plots for clustering analyses were performed using the web tool Morpheus (<ext-link ext-link-type="uri" xlink:href="https://software.broadinstitute.org/morpheus">https://software.broadinstitute.org/morpheus</ext-link>) [<xref ref-type="bibr" rid="R31">31</xref>]. Metascape was used to provide GO terms enrichment [<xref ref-type="bibr" rid="R32">32</xref>] obtained from aged blood genes that potentially interact with SARS-CoV-2.</p>
</sec>
</sec>
<sec id="S11" sec-type="results">
<title>Results</title>
<sec id="S12">
<title>The number of differentially expressed genes and the complexity of associated functions increase in the whole blood during aging</title>
<p id="P15">The number of DEGs varied significantly throughout aging (Log2 FC ≥ |1| ≤ |1| and FDR ≥ 0.05; <xref ref-type="supplementary-material" rid="SD1">Tables S1-S5</xref>). We detected an increased number of DEGs in subjects with 50-59 years old (62 DEGs; 53 up- and 9 downregulated, respectively), 60-69 (251 DEGs; 212 up- and 39 downregulated, respectively), being the older individuals of 7079 with the highest number (913 DEGs; 498 up- and 415 downregulated, respectively). These DEGs were predicted into PPI networks associated with immune response, cytokine and receptor activity, defense response, response to a stimulus, and signaling receptor binding (<xref ref-type="supplementary-material" rid="SD2">Figure S1 A-C</xref>). Forty-one upregulated genes shared the transcriptional profile during aging and are associated with cytokine-cytokine receptor interaction, lymphocyte and natural killer chemotaxis, and eosinophil migration (FDR &lt; 0.05, combined score &gt; 86.06; <xref ref-type="supplementary-material" rid="SD2">Figure S1 D-E</xref> and <xref ref-type="supplementary-material" rid="SD1">Tables S6-S7</xref>). The most prominent molecular functions were binding, regulation, and catalytic activity, while protein classes included those related to immunity, transcriptional regulator, signaling molecule, and protein modifying enzyme (<xref ref-type="supplementary-material" rid="SD2">Figure S1 F</xref>). Seven down-regulated genes shared the transcriptional profile during aging and mostly associated with apolipoprotein receptor binding, regulation of low-density lipoprotein, protein autoprocessing, negative regulation of receptor binding, and receptor-mediated endocytosis (FDR &lt; 0.05, combined score &gt; 75.90; <xref ref-type="supplementary-material" rid="SD2">Figure S1 G-H</xref> and <xref ref-type="supplementary-material" rid="SD1">Tables S6-S8</xref>). The catalytic activity, molecular regulator, transducer, and transcription activities were the most common molecular functions, while protein classes included transcriptional regulator, protein binding activity, protein modifying enzyme, and carrier protein (<xref ref-type="supplementary-material" rid="SD2">Figure S1 I</xref>). Upregulated and downregulated profiles of DEGs are depicted in the volcano plots (<xref ref-type="supplementary-material" rid="SD2">Figure S1 J</xref>).</p>
</sec>
<sec id="S13">
<title>Virus-host PPI interactions reveal increased expression of potential targets in whole blood during aging</title>
<p id="P16">Next, we used the list of DEGs during aging to identify transcripts translated into proteins that potentially interact with SARS-CoV proteins based on P-HIPSTer database. This analysis identified 22 genes with an age-dependent expression profile (<xref ref-type="supplementary-material" rid="SD1">Table S9</xref>; <xref ref-type="fig" rid="F1">Figure 1 A</xref>). Younger individuals (20-29, 30-39, and 40-49 years old) showed similarities and were distinctly clustered than older individuals (50-59, 60-69, and 70-79 years old). By comparing clusters two by two, the age range of 20-29 years old showed a unique mean expression pattern compared to other aging groups (<xref ref-type="supplementary-material" rid="SD2">Figure S2</xref>). Among DEGs translated into predicted proteins interacting with SARS-CoV, most of them appeared overexpressed in the age range of 50-79 years old (<xref ref-type="fig" rid="F1">Figure 1 B and C</xref>); while <italic>FASLG</italic> appeared overexpressed in individuals aged 50-59, 60-69, and 70-79, the <italic>CTSW, CTSE, VCAM1 and BAG3</italic> targets were commonly overexpressed in the two older groups of individuals (60-69 and 70-79 years-old). The exclusive DEGs in individuals of 60-79 years old were <italic>HBQ1, HSPA5, EPB41L3, SRC, PDCD1, CD7,</italic> <italic>CD8A, IGSF9, EPB41L4A, FRMPD3, and SCN2B.</italic> After investigating tissue-specific functional modules using these DEGs, we observed a consistent interaction of whole blood proteins as being mostly associated with natural killer cells (<xref ref-type="fig" rid="F1">Figure 1 D</xref>).</p>
<p id="P17">We generated a PPI network for all over-represented targets using the STRING database (enrichment p-value &lt; 1.0e-16, highest confidence of 0.09; <xref ref-type="fig" rid="F1">Figure 1 E</xref>). This analysis highlighted <italic>FASLG, SRC, VCAM1, BAG3,</italic> and <italic>HSPA5</italic> as the main interactions involved in immune response, inflammation, and platelet activation and aggregation; these proteins are directly or indirectly associated with the plasma membrane. To identify top enriched terms, we performed gene ontology (GO) analysis using these targets to unravel aged blood's functional significance with virus-host PPI. The most relevant processes and molecular function included the immune system process, cellular component organization, biological adhesion, signaling and response to a stimulus, regulation of the biological process, and developmental process (<xref ref-type="fig" rid="F1">Figure 1 F</xref>). Although CTSW and CTSE proteins are related to viral endosomal escape, FASLG, VCAM1, and BAG3 interact with viral Orf8 and protein sars7a (<xref ref-type="supplementary-material" rid="SD1">Tables S10</xref> and <xref ref-type="supplementary-material" rid="SD1">S11</xref>). Also, VCAM1 and BAG3 showed potential interaction with spike glycoprotein, E2 glycoprotein precursors, Excised polyprotein 1..4369 (gene: orf1ab), and Full_polyprotein 1..4382.</p>
</sec>
<sec id="S14">
<title>Gender-dependent transcriptional responses in whole blood during aging</title>
<p id="P18">We further compared mean gene expression in a cohort with female and male samples to identify gender-dependent responses (GTEx, release V8). When we compared male and female blood samples together, we found that expression of <italic>FASLG, CTSW, CTSE,</italic> and <italic>BAG3</italic> genes significantly increased throughout aging (<xref ref-type="fig" rid="F2">Figure 2</xref>). <italic>VCAM1</italic> was the only transcript that increases its levels in individuals of 6069 years old compared with younger individuals (20-29 years old). The gene expression profile in the whole blood of male and females samples were similar. Notably, <italic>FASLG</italic> showed an increased expression over the age of 50 in the blood of males and females in a similar manner (<xref ref-type="supplementary-material" rid="SD2">Figures S2</xref> and <xref ref-type="supplementary-material" rid="SD2">S3</xref>). Among all DEGs, <italic>CTSW</italic> presented a similar expression profile in males and females. The <italic>CTSE</italic> was higher in males &gt; 50 years old compared to females. Specifically, <italic>VCAM1</italic> and <italic>BAG3</italic> showed age-dependent expressions when men and women were analyzed individually (<xref ref-type="supplementary-material" rid="SD2">Figure S2 and S3</xref>).</p>
</sec>
<sec id="S15">
<title>FASL is predominantly expressed by NK cells and CD8+ T cells</title>
<p id="P19">We analyzed the expression profile of our candidate genes <italic>(FASLG, CTSW,</italic> <italic>CTSE, VCAM1,</italic> and <italic>BAG3)</italic> to identify blood cell subpopulations in single-cell RNA sequencing (scRNA-seq) data of peripheral mononuclear blood cells from SARS-CoV-2-infected patients. Of note, natural killer (NK) cells, CD8+ T cells, and alpha-beta memory T cells were associated with the expressions of <italic>FASLG</italic> and <italic>CTSW</italic> genes, the latter being expressed by a higher number of immune cells (<xref ref-type="fig" rid="F3">Figure 3 A and B</xref>). Also, <italic>BAG3</italic> gene was mainly expressed in CD4+ alpha-beta memory T cells, naive T cells, and in CD14+ monocytes (<xref ref-type="fig" rid="F3">Figure 3 C</xref>). We also noticed that <italic>VCAM1</italic> and <italic>CTSE</italic> genes were minimally expressed by these blood cells (<xref ref-type="fig" rid="F3">Figure 3 D and E</xref>).</p>
<p id="P20">Fas ligand (FasL) comprises 281 amino acids (aa) and is divided into a C-terminal intracellular domain (1-80 aa), a transmembrane domain (81-102 aa), a N-terminal extracellular domain (103-281 aa) (<xref ref-type="fig" rid="F4">Figure 4 A</xref>). While FasL N-terminal extracellular domain is responsible for self-association, the FasL C-terminal intracellular domain has a function of receptor binding (PDB ID: 4MSV, chain A; <xref ref-type="fig" rid="F4">Figure 4 B</xref>). Its Fas receptor comprises 335 aa, which are divided into a putative signal sequence of 16 aa (the N-terminal domain with 155 aa, the transmembrane region with 19 aa, and the C-terminal domain with 145 aa (<xref ref-type="fig" rid="F4">Figure 4 C and D</xref>). Although structurally unresolved, the complex Fas/FasL is formed by binding of trimeric FasL to Fas, resulting in signaling-competent trimers that lead to the assembly of death-inducing signaling complex (DISC) with intracellular proteins. <xref ref-type="fig" rid="F5">Figure 5</xref> summarizes the possible mechanistic role of Fas/FasL signaling activation after SARS-CoV-2 viruses enter the bloodstream and interact with T cells and NK cells. This may result in exacerbated immune response throughout the organism in addition to inducing exhaustion of particular blood cells.</p>
</sec>
</sec>
<sec id="S16" sec-type="discussion">
<title>Discussion</title>
<p id="P21">The multi-systemic involvement associated with rapid clinical deterioration is among the hallmarks of COVID-19-related mortality. Blood components are deeply involved with widespread virus dissemination and disease aggressiveness; recent approaches uncovered that coronavirus's immune responses persist beyond six months[<xref ref-type="bibr" rid="R33">33</xref>]. To better understand what happens with the blood of patients over aging, we investigated the virus-host interactions using whole blood samples of a young adult compared with older adult individuals. In general, a distinct profile of blood targets was clustered with younger ages (20-49) and older ages (50-79), in which the most distant groups (20-29 years old versus 70-79 years old) displayed an inverse gene expression pattern. The most pronounced effects were observed over the age of 50 and included higher expression of SARS-CoV-2-related genes (e.g., genes involved in immune response, inflammation, cell component and adhesion, biological process, and platelet activation/aggregation). The increase in inflammatory mediators strongly correlates with disease severity within the conception of cytokine storm [<xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R35">35</xref>]. Since blood diffuses through the capillaries to guarantee tissue perfusion, the multiple organ dysfunction syndrome may be likely due to essential elements arising from cytokine storm; therefore, monitoring cytokines reduce mortality in other viral diseases such as SARS, MERS, and influenza [<xref ref-type="bibr" rid="R36">36</xref>]. Unlike an early infection, the advanced disease is associated with low levels of the antiviral interferons (IFNs) and high levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF) and chemokines (CCL-2, CCL-3, and CCL-5) secreted by coronavirus-infected immune cells [<xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R38">38</xref>].</p>
<p id="P22">We provided herein a transcriptomic investigation to identify a possible signature of reliable candidates involved with aged blood. While FASLG was found to be overexpressed in the three highest age ranges of 50-59, 60-69, 70-79 years, some cathepsins (CTSW and CTSE), adhesion-related molecule (VCAM1), and chaperone regulator molecule (BAG3) were commonly increased after the age of 60. FasL is a type-II transmembrane and homotrimeric protein belonging to the tumor necrosis factor (TNF) family After binding to its Fas receptor, a type-I transmembrane TNF receptor, FasL triggers apoptotic and highly inflammatory activities [<xref ref-type="bibr" rid="R39">39</xref>]. Although Fas-FasL signaling has shown involvement in apoptosis of immune cells and virus-infected-target cells [<xref ref-type="bibr" rid="R40">40</xref>], emerging evidence highlights the apoptosis-independent role of Fas-FasL on the induction of active pro-inflammatory signals in severe pathological conditions (e.g., viral infection) [<xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R42">42</xref>]. FasL promotes T cell activation in humans by recruiting Cflip to the DISC, thereby activating NF-kB and ERK/AP-1 transcription factors [<xref ref-type="bibr" rid="R43">43</xref>]. These activations were responsible for the secretion of IL-2 and T cell proliferation; IL-8 was also associated with NF-kB transactivation in bronchiolar epithelial cells, whereas macrophages secreted TNF-α after Fas ligation [<xref ref-type="bibr" rid="R44">44</xref>] without triggering apoptotic signaling. Consistently with these findings, we detected by single-cell analysis that FasL is mainly secreted by CD8+ T and NK cells in the peripheral blood of SARS-CoV-2-infected patients. More importantly, a possible interaction of viral Orf8 with a variety of host proteins including FasL may explain the rapid spread of the coronavirus and immune evasion, since Orf8 of SARS-CoV-2 is highly secreted and downregulated MHC-I in cells [<xref ref-type="bibr" rid="R45">45</xref>]. A recent study by Sorbera et al. [<xref ref-type="bibr" rid="R46">46</xref>] on specific SARS-CoV-2-induced targets reported Fas-FasL signaling involved with endothelial function and neutrophil lifespan and related SARS-CoV-induced apoptosis with potential viral replication. Thus, inhibiting Fas/FasL interaction may be useful in the treatment of COVID-19.</p>
<p id="P23">A comprehensive study using whole blood samples from 54 COVID-19 patients documented a dramatic increase in immature neutrophils in parallel with a decrease in CD8+ T and VD2 γδ T-cells count, which is likely due to its differentiation and activation [<xref ref-type="bibr" rid="R47">47</xref>]. Based on this fact, we believe that the low count of FasL-associated CD8+ T cells could result from its activation. The immune responses to SARS-CoV-2 infection are often characterized by hyperactivation of CD4+ and CD8+ T cells [<xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref>] and macrophages [<xref ref-type="bibr" rid="R50">50</xref>], which produce massive levels of pro-inflammatory cytokines. Current evidence reports that critically ill patients have elevation in IL-6 levels compared to moderately ill patients [<xref ref-type="bibr" rid="R35">35</xref>]; in addition to the infiltration of inflammatory cells, immune cells have been found in patients's lung tissues. Notably, disease-associated transcriptional change in aged whole blood had a more pronounced overlap with control blood in comparison to lung tissue transcriptome [<xref ref-type="bibr" rid="R51">51</xref>]. By interacting host genes with SARS-CoV-2 and blood transcriptome, Bhattacharyya and Thelma [<xref ref-type="bibr" rid="R51">51</xref>] further suggested that viral infection only alters expression profile already dysregulated in the elderly, thereby resulting in poor prognosis; these altered blood genes may reinforce the appearance of severe clinical manifestations including strokes, blood clots, and heart failures.</p>
<p id="P24">The expression of CTSW, CTSE, VCAM1, and BAG3 was further shared in the two last age ranges compared to young individuals. Cathepsins SW (CTSW) and SE (CTSE) are papain-like cysteine protease and intracellular aspartic protease, respectively. These molecules were mainly overexpressed in males compared to females. The cathepsins B/L have been described to mediate viral entry into host cells via the endosomal pathway, participating in cell death, protein degradation, autophagy, and immune activities [<xref ref-type="bibr" rid="R52">52</xref>–<xref ref-type="bibr" rid="R54">54</xref>]. Although CTSB and CTSL are mainly associated with SARS-CoV-2 infection, CTSW is involved in the escape of viral particles from late endosomes during influenza A virus (IAV) replication [<xref ref-type="bibr" rid="R55">55</xref>]. Otherwise, CTSE is expressed in immune cells being implicated in antigen processing MHC class II pathway [<xref ref-type="bibr" rid="R56">56</xref>]. Targeting CTSW and CTSE may also be a promising alternative to treat COVID-19.</p>
<p id="P25">Serum levels of VCAM1 are elevated in mild COVID-19 and highly increased in severe cases [<xref ref-type="bibr" rid="R57">57</xref>]. There are several pathological evidence of thromboembolism, diffuse endothelial inflammation, and viral infection of endothelial cells [<xref ref-type="bibr" rid="R58">58</xref>,<xref ref-type="bibr" rid="R59">59</xref>] that are strictly related to disease severity and dysfunctional coagulation. Importantly, it is of great value to investigate the expression of endothelial cell adhesion molecules in aged COVID-19 patients.</p>
<p id="P26">The BAG3, an anti-apoptotic co-chaperone molecule referred to as BCL2-associated athanogene 3, was upregulated in naive T cells, CD4+ T cells, and CD14+ T cells from aged individuals. BAG3 is involved in a variety of biological processes such as cell survival and apoptosis, cellular stress response, and cell migration, and is suggested to be part of the SARS-CoV machinery for replication [<xref ref-type="bibr" rid="R60">60</xref>]. In this context, BAG3 inhibition seems to promote a significant suppresion of viral replication. Like VCAM1, the BAG3 is predicted to interact with spike (S) glycoproteins. These surface molecules favor virus attachment, fusion, and entry into host cells as a direct target involved in immune responses, being lately evaluated for design and development of the S protein-based vaccines [<xref ref-type="bibr" rid="R61">61</xref>]. After SARS-CoV-2 enters the bloodstream, a cascade of events occurs resulting in blood clots and strokes [<xref ref-type="bibr" rid="R62">62</xref>]. We verified upregulation of proto-oncogene (SRC) and heat-shock protein 70 member 5 (HSPA5) genes in aged individuals (70-79 years old); these are linked to platelet aggregation, activation, and signalings. The other upregulated targets showed involvement in adaptive immunity, immunoglobulin domain, T cell receptor signalings, and cell adhesion. Future approaches are needed to evaluate the role of these blood targets considering COVID-19-related comorbidities and individual physical conditions over aging.</p>
</sec>
<sec id="S17" sec-type="conclusions">
<title>Conclusion</title>
<p id="P27">In summary, we demonstrated that blood gene expression of FASLG, a Fas receptor-ligand triggering non-apoptotic inflammatory activities, is overexpressed in NK cells and CD8+ T cells of males and females after the age of 50. Our in-depth study further evidenced the increase in some cathepsins, cell adhesion, and co-chaperone molecules potentially involved in host cell entry, replication, and vascular dysfunction during aging. Because hypercytokinemia is described as the framework for disease severity and high-risk death, we highlight FASL as a prognostic biomarker and a therapeutic proposal to modulate inflammation in elderly patients with COVID-19. Additional studies are encouraged to test the presence of this biomarker in different disease modalities.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<p id="P28">Supplementary materials can be downloaded directly at the site.</p>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Table</label>
<media xlink:href="EMS107871-supplement-Supplementary_Table.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N66536" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supplementary Figures</label>
<media xlink:href="EMS107871-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="N66545" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S18">
<title>Funding</title>
<p>The following grant supported the development of this study: São Paulo Research Foundation (FAPESP grant # 2019/00906-6).</p>
</ack>
<fn-group>
<fn id="FN1" fn-type="conflict">
<p id="P29">
<bold>Conflict of interest:</bold> The authors declare no conflicts of interest.</p>
</fn>
<fn id="FN2">
<p id="P30">
<bold>Authorship</bold>
</p>
<p id="P31">LGAC, RFC: conception of the idea, design of the study and drafted the manuscript; JSS: statistical analysis and acquisition of data; MON, MCM: physical and structural analysis and interpretation. All authors significantly contributed with compilation of the literature and approved the final version of the manuscript.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>[1]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boulware</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Pullen</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Bangdiwala</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Pastick</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Lofgren</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Okafor</surname>
<given-names>EC</given-names>
</name>
<etal/>
</person-group>
<article-title>A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19</article-title>
<source>N Engl J Med</source>
<year>2020</year>
<comment>NEJMoa2016638</comment>
</element-citation>
</ref>
<ref id="R2">
<label>[2]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sircar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>YS</given-names>
</name>
<etal/>
</person-group>
<article-title>Coronavirus Disease 2019-COVID-19</article-title>
<source>Clin Microbiol Ver</source>
<year>2020</year>
<volume>33</volume>
<fpage>e00028</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="R3">
<label>[3]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Blet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The science underlying COVID-19: implications for the cardiovascular system</article-title>
<source>Circulation</source>
<year>2020</year>
<volume>142</volume>
<fpage>68</fpage>
<lpage>78</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>[4]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porfidia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Valeriani</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pola</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Porreca</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rutjes</surname>
<given-names>AWS</given-names>
</name>
<name>
<surname>Di Nisio</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis</article-title>
<source>Thromb Res</source>
<year>2020</year>
<volume>196</volume>
<fpage>67</fpage>
<lpage>74</lpage>
</element-citation>
</ref>
<ref id="R5">
<label>[5]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Samkari</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Karp Leaf</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Dzik</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>JCT</given-names>
</name>
<name>
<surname>Fogerty</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Waheed</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection</article-title>
<source>Blood</source>
<year>2020</year>
<volume>136</volume>
<fpage>489</fpage>
<lpage>500</lpage>
</element-citation>
</ref>
<ref id="R6">
<label>[6]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coccheri</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>COVID-19: The crucial role of blood coagulation and fibrinolysis</article-title>
<source>Intern Emerg Med</source>
<year>2020</year>
<volume>15</volume>
<fpage>1369</fpage>
<lpage>73</lpage>
</element-citation>
</ref>
<ref id="R7">
<label>[7]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>k</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients</article-title>
<source>J Infect</source>
<year>2020</year>
<volume>80</volume>
<fpage>e14</fpage>
<lpage>e18</lpage>
</element-citation>
</ref>
<ref id="R8">
<label>[8]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>395</volume>
<fpage>497</fpage>
<lpage>506</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>[9]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zietz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zucker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tatonetti</surname>
<given-names>NP</given-names>
</name>
</person-group>
<article-title>Testing the association between blood type and COVID-19 infection, intubation, and death</article-title>
<source>MedRxiv preprint</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.08.20058073</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>[10]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>D-Z</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J-N</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>W-Q</given-names>
</name>
</person-group>
<article-title>Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis</article-title>
<source>Infect Genet Evol</source>
<year>2020</year>
<volume>84</volume>
<fpage>104485</fpage>
</element-citation>
</ref>
<ref id="R11">
<label>[11]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</article-title>
<source>Cell Discov</source>
<year>2020</year>
<volume>6</volume>
<fpage>14</fpage>
</element-citation>
</ref>
<ref id="R12">
<label>[12]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lasso</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Winkelmann</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Elliot</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Patino-Galindo</surname>
<given-names>JA</given-names>
</name>
<etal/>
</person-group>
<article-title>A Structure-Informed Atlas of Human-Virus Interactions</article-title>
<source>Cell</source>
<year>2019</year>
<volume>178</volume>
<fpage>1526</fpage>
<lpage>1541.e16</lpage>
</element-citation>
</ref>
<ref id="R13">
<label>[13]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Understanding Human-Virus Protein-Protein Interactions Using a Human Protein Complex-Based Analysis Framework</article-title>
<source>mSystems</source>
<year>2019</year>
<volume>4</volume>
<fpage>e00303</fpage>
<lpage>18</lpage>
</element-citation>
</ref>
<ref id="R14">
<label>[14]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lonsdale</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salvatore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shad</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>The Genotype-Tissue Expression (GTEx) project</article-title>
<source>Nat Genet</source>
<year>2013</year>
<volume>45</volume>
<fpage>580</fpage>
<lpage>585</lpage>
</element-citation>
</ref>
<ref id="R15">
<label>[15]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ardlie</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Deluca</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Segré</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Gelfand</surname>
<given-names>ET</given-names>
</name>
<etal/>
</person-group>
<article-title>Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title>
<source>Science</source>
<year>2015</year>
<volume>348</volume>
<fpage>648</fpage>
<lpage>60</lpage>
</element-citation>
</ref>
<ref id="R16">
<label>[16]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Oshlack</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Scaling normalization method for differential expression analysis of RNA-seq data</article-title>
<source>Genome Biol</source>
<year>2010</year>
<volume>11</volume>
<fpage>R25</fpage>
</element-citation>
</ref>
<ref id="R17">
<label>[17]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torre</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lachmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ma'ayan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>BioJupies: Automated Generation of Interactive Notebooks for RNA-Seq Data Analysis in the Cloud</article-title>
<source>Cell Syst</source>
<year>2018</year>
<fpage>1</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="R18">
<label>[18]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lasso</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Winkelmann</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Elliot</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Patino-Galindo</surname>
<given-names>JA</given-names>
</name>
<etal/>
</person-group>
<article-title>A Structure-Informed Atlas of Human-Virus Interactions</article-title>
<source>Cell</source>
<year>2019</year>
<volume>178</volume>
<fpage>1526</fpage>
<lpage>1541.e16</lpage>
</element-citation>
</ref>
<ref id="R19">
<label>[19]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moraes</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Paiva</surname>
<given-names>BVB</given-names>
</name>
<name>
<surname>Cury</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>AraújoJunior</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>MAS</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>Prediction of SARS-CoV interaction with host proteins during lung aging reveals a potential role for TRIB3 in COVID-19</article-title>
<source>BioRxiv preprint</source>
<pub-id pub-id-type="doi">10.1101/2020.04.07.030767</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>[20]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Constantino</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Cury</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Nogueira</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Justulin</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Prediction of non-canonical routes for SARS-CoV-2 infection in human placenta cells</article-title>
<source>BioRxiv preprint</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.06.12.148411</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>[21]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greene</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Ricciotti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zelaya</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Himmelstein</surname>
<given-names>DS</given-names>
</name>
<etal/>
</person-group>
<article-title>Understanding multicellular function and disease with human tissue-specific networks</article-title>
<source>Nat Genet</source>
<year>2015</year>
<volume>47</volume>
<fpage>569</fpage>
<lpage>576</lpage>
</element-citation>
</ref>
<ref id="R22">
<label>[22]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuleshov</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Rouillard</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>NF</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>
<source>Nucleic Acids Res</source>
<year>2016</year>
<volume>44</volume>
<fpage>W90</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="R23">
<label>[23]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Muruganujan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>PANTHER version 11 expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements</article-title>
<source>Nucleic Acids Res</source>
<year>2017</year>
<volume>45</volume>
<issue>D1</issue>
<fpage>D183</fpage>
<lpage>D189</lpage>
</element-citation>
</ref>
<ref id="R24">
<label>[24]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gable</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Junge</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wyder</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huerta-Cepas</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title>
<source>Nucleic Acids Res</source>
<year>2019</year>
<volume>47</volume>
<fpage>D607</fpage>
<lpage>D613</lpage>
</element-citation>
</ref>
<ref id="R25">
<label>[25]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilk</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Rustagi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>NQ</given-names>
</name>
<name>
<surname>Roque</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martinez-Colón</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>McKechnie</surname>
<given-names>JL</given-names>
</name>
<etal/>
</person-group>
<article-title>A single-cell atlas of the peripheral immune response in patients with severe COVID-19</article-title>
<source>Nat Med</source>
<year>2020</year>
<volume>26</volume>
<fpage>1070</fpage>
<lpage>1076</lpage>
</element-citation>
</ref>
<ref id="R26">
<label>[26]</label>
<element-citation publication-type="journal">
<collab>NCBI Resource Coordinators</collab>
<article-title>Database resources of the National Center for Biotechnology Information</article-title>
<source>Nucleic Acids Res</source>
<year>2016</year>
<volume>44</volume>
<fpage>D7</fpage>
<lpage>19</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>[27]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Henrick</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Announcing the worldwide Protein Data Bank</article-title>
<source>Nat Struct Biol</source>
<year>2003</year>
<volume>10</volume>
<fpage>980</fpage>
</element-citation>
</ref>
<ref id="R28">
<label>[28]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>A Time-Efficient, Linear-Space Local Similarity Algorithm</article-title>
<source>Adv Appl Math</source>
<year>1991</year>
<volume>12</volume>
<fpage>337</fpage>
<lpage>357</lpage>
</element-citation>
</ref>
<ref id="R29">
<label>[29]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkins</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Gasteiger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bairoch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Appel</surname>
<given-names>RD</given-names>
</name>
<etal/>
</person-group>
<article-title>Protein identification and analysis tools in the ExPASy server</article-title>
<source>Methods Mol Biol</source>
<year>1999</year>
<volume>112</volume>
<fpage>531</fpage>
<lpage>52</lpage>
</element-citation>
</ref>
<ref id="R30">
<label>[30]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveros</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Venny. An interactive tool for comparing lists with Venn's diagrams</article-title>
<year>2007-2015</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R31">
<label>[31]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starruß</surname>
<given-names>J</given-names>
</name>
<name>
<surname>de Back</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Brusch</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Deutsch</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Morpheus: a user-friendly modeling environment for multiscale and multicellular systems biology</article-title>
<source>Bioinformatics</source>
<year>2014</year>
<volume>30</volume>
<fpage>1331</fpage>
<lpage>2</lpage>
</element-citation>
</ref>
<ref id="R32">
<label>[32]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pache</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khodabakhshi</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Tanaseichuk</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>
<article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title>
<source>Nat Commun</source>
<year>2019</year>
<volume>10</volume>
<fpage>1523</fpage>
</element-citation>
</ref>
<ref id="R33">
<label>[33]</label>
<element-citation publication-type="journal">
<article-title>COVID research updates: Immune responses to coronavirus persist beyond 6 months</article-title>
<source>Nature</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/d41586-020-00502-w</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>[34]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhaskar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Banach</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mittoo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Weissert</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kass</surname>
<given-names>JS</given-names>
</name>
<etal/>
</person-group>
<article-title>Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper</article-title>
<source>Front Immunol</source>
<year>2020</year>
<volume>11</volume>
<fpage>1648</fpage>
</element-citation>
</ref>
<ref id="R35">
<label>[35]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies</article-title>
<source>Front Immunol</source>
<year>2020</year>
<volume>11</volume>
<fpage>1708</fpage>
</element-citation>
</ref>
<ref id="R36">
<label>[36]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Cytokine storm intervention in the early stages of COVID-19 pneumonia</article-title>
<source>Cytokine Growth Factor Ver</source>
<year>2020</year>
<volume>53</volume>
<fpage>38</fpage>
<lpage>42</lpage>
</element-citation>
</ref>
<ref id="R37">
<label>[37]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheung</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>LLM</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>IHY</given-names>
</name>
<name>
<surname>Luk</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sia</surname>
<given-names>S-F</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>MHS</given-names>
</name>
</person-group>
<article-title>Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis</article-title>
<source>J Virol</source>
<year>2005</year>
<volume>79</volume>
<fpage>7819</fpage>
<lpage>7826</lpage>
</element-citation>
</ref>
<ref id="R38">
<label>[38]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Law</surname>
<given-names>HKW</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Sia</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>YO</given-names>
</name>
<name>
<surname>Luk</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells</article-title>
<source>Blood</source>
<year>2005</year>
<volume>106</volume>
<fpage>2366</fpage>
<lpage>2374</lpage>
</element-citation>
</ref>
<ref id="R39">
<label>[39]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>FK</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Siegel</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Bui</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Lenardo</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>A domain in TNF receptors that mediates ligand-independent receptor assembly and signalings</article-title>
<source>Science</source>
<year>2000</year>
<volume>288</volume>
<fpage>2351</fpage>
<lpage>2354</lpage>
</element-citation>
</ref>
<ref id="R40">
<label>[40]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bień</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sokołowska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bąska</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nowak</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Krzyzowska</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Fas/FasL Pathway Participates in Regulation of Antiviral and Inflammatory Response during Mousepox Infection of Lungs</article-title>
<source>Mediators Inflamm</source>
<year>2015</year>
<volume>2015</volume>
<fpage>1</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="R41">
<label>[41]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amoras</surname>
<given-names>ESG</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>STM</given-names>
</name>
<name>
<surname>Freitas</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Santana</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Ishak</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Araújo</surname>
<given-names>MTF</given-names>
</name>
<etal/>
</person-group>
<article-title>Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection</article-title>
<source>PLoS One</source>
<volume>11</volume>
<year>2016</year>
<fpage>e0156604</fpage>
</element-citation>
</ref>
<ref id="R42">
<label>[42]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krzyzowska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shestakov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chiodi</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection</article-title>
<source>Cell Death Dis</source>
<year>2011</year>
<volume>2</volume>
<fpage>e132</fpage>
</element-citation>
</ref>
<ref id="R43">
<label>[43]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kataoka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Budd</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Holler</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Thome</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martinon</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Irmler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hahne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kovacsovics</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tschopp</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>The caspase-8 FLIP pro-motes activation of NF-kB and Erk signaling pathways</article-title>
<source>Curr Biol</source>
<year>2000</year>
<volume>10</volume>
<fpage>640</fpage>
<lpage>648</lpage>
</element-citation>
</ref>
<ref id="R44">
<label>[44]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagimoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kuwano</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoshimi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kanako</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kunitake</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Induction of IL-8 secretion and apoptosis in bronchio-lar epithelial cells by Fas ligation</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>1999</year>
<volume>21</volume>
<fpage>436</fpage>
<lpage>445</lpage>
</element-citation>
</ref>
<ref id="R45">
<label>[45]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flower</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Buffalo</surname>
<given-names>CZ</given-names>
</name>
<name>
<surname>Hooy</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Allaire</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hurley</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Structure of SARS-CoV-2 ORF8, a rapidly evolving coronavirus protein implicated in immune evasion</article-title>
<source>BioRxiv pre-print</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.08.27.270637</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>[46]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorbera</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Graul</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Dulsa</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Taking aim at a fast-moving target: targets to watch for SARS-CoV-2 and COVID-19</article-title>
<source>Drugs of the Future</source>
<year>2020</year>
<volume>45</volume>
<fpage>1</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="R47">
<label>[47]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carissimo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kwok</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Abdad</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>Y-H</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>S-W</given-names>
</name>
<etal/>
</person-group>
<article-title>Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19</article-title>
<source>Nat Commun</source>
<year>2020</year>
<volume>11</volume>
<comment>5243</comment>
</element-citation>
</ref>
<ref id="R48">
<label>[48]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>John Wherry</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>T cell responses in patients with COVID-19</article-title>
<source>Nature Rev Immunol</source>
<year>2020</year>
<volume>20</volume>
<fpage>529</fpage>
<lpage>536</lpage>
</element-citation>
</ref>
<ref id="R49">
<label>[49]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>J-W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>F-P</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Immunological and inflammatory profiles in mild and severe cases of COVID-19</article-title>
<source>Nat Commun</source>
<year>2020</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>10</lpage>
</element-citation>
</ref>
<ref id="R50">
<label>[50]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages</article-title>
<source>Nature Rev Immunol</source>
<year>2020</year>
<volume>20</volume>
<fpage>355</fpage>
<lpage>362</lpage>
</element-citation>
</ref>
<ref id="R51">
<label>[51]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharyya</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Thelma</surname>
<given-names>BK</given-names>
</name>
</person-group>
<article-title>Age-related gene expression alterations by SARS-CoV-2 infection contribute to poor prognosis in elderly</article-title>
<source>J Genet</source>
<year>2020</year>
<volume>99</volume>
<fpage>80</fpage>
</element-citation>
</ref>
<ref id="R52">
<label>[52]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kleine-Weber</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Krüger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Herrler</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Erichsen</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by aClinically Proven Protease Inhibitor</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<fpage>271</fpage>
<lpage>280</lpage>
</element-citation>
</ref>
<ref id="R53">
<label>[53]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Libby</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>G-P</given-names>
</name>
</person-group>
<article-title>Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients</article-title>
<source>Pharmacol Ther</source>
<year>2020</year>
<volume>213</volume>
<fpage>107587</fpage>
</element-citation>
</ref>
<ref id="R54">
<label>[54]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simmons</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gosalia</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Rennekamp</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Reeves</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Bates</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Inhibitors of cathepsinL prevent severe acute respiratory syndrome coronavirus entry</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>2005</year>
<volume>102</volume>
<fpage>11876</fpage>
<lpage>11881</lpage>
</element-citation>
</ref>
<ref id="R55">
<label>[55]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edinger</surname>
<given-names>TO</given-names>
</name>
<name>
<surname>Pohl</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Yángüez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stertz</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes</article-title>
<source>mBio</source>
<year>2015</year>
<volume>6</volume>
<fpage>e00297</fpage>
<lpage>15</lpage>
</element-citation>
</ref>
<ref id="R56">
<label>[56]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kalbacher</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Cathepsin E: A mini review</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2008</year>
<volume>367</volume>
<fpage>517</fpage>
<lpage>22</lpage>
</element-citation>
</ref>
<ref id="R57">
<label>[57]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients</article-title>
<source>J Infect Dis</source>
<year>2020</year>
<volume>222</volume>
<fpage>894</fpage>
<lpage>898</lpage>
</element-citation>
</ref>
<ref id="R58">
<label>[58]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varga</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Flammer</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Steiger</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haberecker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Andermatt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zinkernagel</surname>
<given-names>AS</given-names>
</name>
<etal/>
</person-group>
<article-title>Endothelial cell infection and endotheliitis in COVID-19</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>395</volume>
<fpage>14178</fpage>
</element-citation>
</ref>
<ref id="R59">
<label>[59]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wichmann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sperhake</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Lütgehetmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Steurer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Edler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Autopsy findings and venous thromboembolism in patients with COVID-19 a prospective cohort study</article-title>
<source>Ann Intern Med</source>
<year>2020</year>
<volume>173</volume>
<fpage>268</fpage>
<lpage>277</lpage>
</element-citation>
</ref>
<ref id="R60">
<label>[60]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z-P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X-E</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>F-S</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication</article-title>
<source>J Virol</source>
<year>2010</year>
<volume>84</volume>
<fpage>6050</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R61">
<label>[61]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens</article-title>
<source>Front Immunol</source>
<year>2020</year>
<volume>11</volume>
<fpage>576622</fpage>
</element-citation>
</ref>
<ref id="R62">
<label>[62]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janardhan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Janardhan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kalousek</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>COVID J19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy</article-title>
<source>J Neuroimaging</source>
<year>2020</year>
<volume>30</volume>
<fpage>555</fpage>
<lpage>561</lpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Identification of molecular targets that potentially interact with SARS-CoV-2 and its functions associated with whole blood during aging.</title>
<p>A) Heatmap illustrating the differentially expressed genes (DEGs; mean expression) based on virus-host interactions. Clustering analysis was performed in whole blood samples by age and target using Euclidian distance. B) Venn diagram showing common and exclusive DEGs during aging after matching with SARS-CoV-2-interacting proteins. C) Heat-scatter plot presenting 22 DEGs in the whole blood during aging. The color of the circles in the plot reveals the Log<sub>2</sub>FC, while the size reflects the −Log<sub>10</sub> transformed FDR adjusted p-value. Fold-change was used to represent gene expression in blood samples in the three most advanced ages (50-59, 60-69, and 70-79 years old). D) Tissue-specific gene network of blood proteins predicted to interact with SARS-CoV-2. The network was generated using the HumanBase online tool (<ext-link ext-link-type="uri" xlink:href="https://hb.flatironinstitute.org/">https://hb.flatironinstitute.org/</ext-link>). E) PPI interaction of proteins identified as differentially regulated illustrating the top three enriched terms and pathways. Functional interaction analysis was performed with STRING (PPI enrichment p-value &lt; 1.0e-16; minimum confidence score: 0.9). F) Functional enrichment analysis (GO terms) using all DEGs of the blood during the aging process was generated in the Metascape tool (<ext-link ext-link-type="uri" xlink:href="https://metascape.org">https://metascape.org</ext-link>).</p>
</caption>
<graphic xlink:href="EMS107871-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Gene expression levels (TMM) of common targets in whole blood over aging.</title>
<p>Data are represented in boxplot by mean ± SD. * P &lt; 0.05, ** P &lt; 0.001, and *** P &lt; 0.0001 vs. young adult individuals (20-29 years old). ANOVA complemented by Tukey's test. <italic>FASLG:</italic> tumor necrosis factor ligand superfamily member 6; <italic>CTSE:</italic> cathepsin E; <italic>CTSW:</italic> cathepsin W; <italic>VCAM1:</italic> vascular cell adhesion molecule 1; <italic>BAG3:</italic> BAG family molecular chaperone regulator 3.</p>
</caption>
<graphic xlink:href="EMS107871-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Single-cell gene expression analyses of <italic>FASLG, CTSE, CTSW, VCAM1</italic> and <italic>BAG3</italic> in peripheral mononuclear blood cells (PMBC).</title>
<p>Regional clustering depicting distinct cell populations identified in the blood samples of SARS-CoV-2-infected patients in a <italic>t</italic>-distributed Stochastic Neighbor Embedding (tSNE) plot (upper panel). Green dots represent single cells from PMBC samples, and these were not included in the analysis. The range represents the minimum and maximum expression. Colored cell subgroups are shown by the total number in the legend.</p>
</caption>
<graphic xlink:href="EMS107871-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>FasL and Fas high resolution structures.</title>
<p>A) Alignment of the full FasL sequence with the pdb structures sequences. B) Extracellular domain of the FasL, PDB ID: 4MSV chain A. The structure is shown in cartoon mode from N-terminal (blue color) to C-terminal (red color). C) Alignment of the full Fas sequence with the pdb structures sequences. D) Fas receptor structure displaying the extracellular domain (ECD), PDB ID: 3THM chain F (left panel), the trimer association of the transmembrane domain (TM), PDB ID: 2NA7 (middle panel), and the cytoplasmic death domain (DD), PDB ID: 1DDF (right panel). The structures are shown in cartoon mode from N-terminal (blue color) to C-terminal (red color).</p>
</caption>
<graphic xlink:href="EMS107871-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>Possible mechanisms underlying the Fas-FasL-mediated signaling in the immune cells after SARS-CoV-2 infection.</title>
<p>By infecting specific immune cells, the cytokine storm takes place with elevation in interleukins and chemokines such as IL-1, IL-2, IL-10, IFNs, TNF-α, IP-10, like others. In addition to inflammatory mediators, FasL ligand is highly released by these immune cells, which, in turn, bind to its Fas receptor in the target cell. Upon FasL binding, the apoptosis inhibitor cFLIP is upregulated at the post-translational level and is associated with TRAF1 and TRAF2 and with the kinases RIP and Raf-1, resulting in activation of NF-kB transcription factor and ERK signaling. These anti-apoptotic signals lead to potentiated pro-inflammatory effects via Fas engagement, while FasL increases activated human T cells' proliferation. Fas, death receptor; FasL, Fas ligand (tumor necrosis factor ligand superfamily member 6); NK, natural killer; T, type of lymphocyte; TCR, T-cell receptor; IL-1, interleukin1; IL-2, interleukin2; IL-10, interleukin 10; TNF-α, tumor necrosis factor alpha; IP-10, interferon gamma-induced protein 10; FADD, FAS-associated protein with death domain; cFLIP, FADD-like IL-1β-converting enzyme-inhibitory protein; NF-kB, nuclear factor kappa B; ERK, extracellular signal-regulated kinase.</p>
</caption>
<graphic xlink:href="EMS107871-f005"/>
</fig>
</floats-group>
</article>
